Stacchini A, Carucci P, Pacchioni D, Accinelli G, Demurtas A, Aliberti S, Bosco M, Bruno M, Balbo Mussetto A, Rizzetto M, Bussolati G, De Angelis C
Flow Cytometry Unit, Department of Pathology, Molinette Hospital, Turin, Italy.
Cytopathology. 2012 Feb;23(1):50-6. doi: 10.1111/j.1365-2303.2010.00842.x. Epub 2011 Jan 10.
Although endoscopic ultrasound combined with fine needle aspiration (EUS-FNA) is rapidly becoming the preferred diagnostic approach for the sampling and diagnosis of gastrointestinal and mediastinal malignancies, there are limited data as to its use in the diagnosis of lymphoproliferative disorders. Therefore, we carried out a retrospective evaluation of the performance of EUS-guided FNA combined with flow cytometry (FC) as a tool to improve overall sensitivity and specificity in the diagnosis of lymphoma.
Of 1560 patients having EUS-guided FNA during the period of the study, a total of 56 patients were evaluated by cytology with FC after EUS-FNA. There was adequate material to perform FC analysis for all but one case.
EUS-FNA-FC gave a diagnosis of lymphoma in 11 cases and of reactive lymphadenopathy in 20. A specific histological type was defined by FC alone in eight cases. The remaining cases were diagnosed later by cytology and cell block sections: 13 carcinomas, nine granulomatous lymphadenopathies and one mediastinal extramedullary haematopoiesis. One case was considered only suspicious for lymphoma on cytology and FC but was not confirmed on molecular analysis and one had insufficient material for FC.
Our results show that a combination of EUS-FNA-FC is a feasible and highly accurate method, which may be used for the diagnosis and subtyping of deep-seated lymphoma, providing a significant improvement to cytomorphology alone both for diagnosis and treatment planning, as long as immunocytochemistry is available for non-lymphoma cases.
尽管内镜超声联合细针穿刺抽吸术(EUS-FNA)正迅速成为胃肠道和纵隔恶性肿瘤采样与诊断的首选诊断方法,但关于其在淋巴增生性疾病诊断中的应用数据有限。因此,我们对EUS引导下FNA联合流式细胞术(FC)作为提高淋巴瘤诊断总体敏感性和特异性的工具的性能进行了回顾性评估。
在研究期间接受EUS引导下FNA的1560例患者中,共有56例患者在EUS-FNA后接受了FC细胞学评估。除1例病例外,其余均有足够的材料进行FC分析。
EUS-FNA-FC诊断出11例淋巴瘤和20例反应性淋巴结病。仅通过FC确定了8例特定的组织学类型。其余病例后来通过细胞学和细胞块切片诊断:13例癌、9例肉芽肿性淋巴结病和1例纵隔髓外造血。1例在细胞学和FC检查中仅怀疑为淋巴瘤,但分子分析未得到证实,1例没有足够的材料进行FC检查。
我们的结果表明,EUS-FNA-FC联合是一种可行且高度准确的方法,可用于深部淋巴瘤的诊断和亚型分类,只要非淋巴瘤病例可进行免疫细胞化学检查,就能在诊断和治疗规划方面显著改善单纯细胞形态学诊断。